Oct 01, 2026
Foghorn Therapeutics (FHTX) Plummets 49% as Eli Lilly Terminates Cancer Partnership
Foghorn Therapeutics (FHTX) plunged 49% after Eli Lilly terminated their cancer drug partnership following poor Phase 1 results. Company cuts 40% of staff.
The post Foghorn Therapeutics (FHTX) Plummets 49% as Eli Lilly Terminates Cancer Partnership appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
UNI Wallet Creation Reaches Highest Level Since November 2022
- 2 hours ago
Rocket Lab (RKLB) Stock: Surges as Electron Completes 98th Launch for HawkEye 36...
- 5 hours ago
Cosmos (ATOM) Price Prediction: Can ATOM Reach $15?
- 5 hours ago
XRP News: Why Korea’s KYC-Ready Traders Could Fast-Track XRP Tokenization
- 7 hours ago
Robinhood sees surge in bitcoin, gold prediction markets as traders move beyond...